[The erysipelas as complication of a lymph oedema after therapy of mastocarcinomas (author's transl)].
1812 patients with mastocarcinomas were submitted to a combined therapy (surgery and radiotherapy); 34.2% of them developed an oedema. This inflammation is a complicating factor because it may increase the oedematous tendency. The authors discuss the correlations between a disturbed defluxion and an erysipelas tendency as well as the risks of a chronic stasis. These correlations necessitate an immediate and intensive treatment of the erysipelas.
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D004886:Erysipelas / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D006801:Humans; D008209:Lymphedema / Q000150:complications* / Q000209:etiology; D008875:Middle Aged; D011182:Postoperative Care; D011183:Postoperative Complications; D011878:Radiotherapy / Q000009:adverse effects
D000900:Anti-Bacterial Agents
Das Erysipel als Komplikation bei Lymphödem nach Therapie des Mammakarzinoms.